Reviva Pharmaceuticals Holdings (RVPH) Shares Outstanding (2018 - 2026)

Reviva Pharmaceuticals Holdings has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $7.0 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 200.51% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (up 200.51% YoY) and the FY2025 annual result came in at $3.6 million, up 118.89% from the prior year.
• Shares Outstanding (Entity) advanced to $7.0 million in Q1 2026 per RVPH's latest filing, from $3.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $7.0 million in Q1 2026 and troughed at $756664.0 in Q1 2022.
• A 5-year average of $2.0 million and a median of $1.4 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) climbed 10.77% in 2022, then surged 200.51% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $1.0 million in 2022, then surged by 36.54% to $1.4 million in 2023, then climbed by 18.73% to $1.7 million in 2024, then soared by 118.89% to $3.6 million in 2025, then surged by 93.58% to $7.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $7.0 million, $3.6 million, and $3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.